Cardiol Therapeutics Inc - Class A

CRDL NASDAQ Santé & Biotech Monde
1.03 $
3.74 %

Cardiol Therapeutics développe des thérapies à base de cannabinoïdes pour le traitement des maladies inflammatoires cardiaques et d'autres affections médicales.

Performance & Momentum

6 Months
1 Year 29.45 %
3 Years 37.52 %
5 Years 56.17 %

Similar stocks to Cardiol Therapeutics Inc - Class A

Anantys Community

Be the first to share your analysis on Cardiol Therapeutics Inc - Class A.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases